Načítá se...
NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
INTRODUCTION: Glioblastoma multiforme (GBM) is the most common primary central nervous (CNS) system malignancy with a poor prognosis. The standard treatment for GBM is neurosurgical resection, followed by radiochemotherapy and adjuvant temozolomide chemotherapy. Predictive biomarkers, such as methyl...
Uloženo v:
| Vydáno v: | Front Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734330/ https://ncbi.nlm.nih.gov/pubmed/33330081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.593578 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|